Myoglobin as a prognostic indicator for outcome in dogs with gastric dilatation-volvulus

Authors

  • Katja N. Adamik DrMedVet,

    1. Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany (Adamik, Schulze, Kohn); and the Department of Clinical Veterinary Medicine, Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland (Burgener, Kovacevic).
    Search for more papers by this author
  • Iwan A. Burgener DrMedVet, DACVIM, DECVIM,

    1. Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany (Adamik, Schulze, Kohn); and the Department of Clinical Veterinary Medicine, Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland (Burgener, Kovacevic).
    Search for more papers by this author
  • Alan Kovacevic DrMedVet, DECVIM,

    1. Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany (Adamik, Schulze, Kohn); and the Department of Clinical Veterinary Medicine, Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland (Burgener, Kovacevic).
    Search for more papers by this author
  • Sebastian P. Schulze MRCVS,

    1. Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany (Adamik, Schulze, Kohn); and the Department of Clinical Veterinary Medicine, Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland (Burgener, Kovacevic).
    Search for more papers by this author
  • Barbara Kohn DrMedVet, DECVIM

    1. Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany (Adamik, Schulze, Kohn); and the Department of Clinical Veterinary Medicine, Division of Small Animal Internal Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland (Burgener, Kovacevic).
    Search for more papers by this author

  • Parts of the study have been presented as an abstract at the EVECCS 2005 in Milan, Italy.

Address correspondence and reprint requests to
Dr. Katja Adamik, Clinic of Small Animal Medicine, University of Munich, Veterinaerstrasse 13, 80539 Munich, Germany. Email: katja-adamik@gmx.de and k.adamik@medizinische-kleintierklinik.de

Abstract

Objective – To determine whether myoglobin (Mb) is a useful prognostic indicator for outcome and to investigate any relationship between Mb and mortality in dogs with gastric dilatation-volvulus (GDV).

Design – Prospective study.

Setting – Veterinary teaching hospital.

Animals – Seventy-two dogs with GDV.

Interventions – Blood sampling.

Measurements and Main Results – Mb levels were measured at the time of diagnosis (Mbt0), 24 hours (Mbt1), and 48 hours (Mbt2) after signs of GDV were recognized. Fifty-seven dogs survived (group I) and 15 dogs did not survive (group II). Mb t0 differed significantly between groups (P=0.04). Mbt0 in group I ranged from <30 to >700 ng/mL (n=57, median 74 ng/mL), and in group II from 34 to >700 ng/mL (n=15, median 238 ng/mL). Analysis of a receiver operating characteristic curve of Mbt0 suggested that the best single cutpoint would be 168 ng/mL (sensitivity 60.0%, specificity 84.2%). Fifty percent of dogs with Mbt0>168 ng/mL were euthanized, while 88.9% with Mbt0<168 ng/mL survived. Mbt1 and Mbt2 differed significantly between groups I and II. Mbt1 in group I ranged from 32 to >700 ng/mL (n=55, median 123 ng/mL), and Mbt1 in group II ranged from 131 to 643 ng/mL (n=7, median 343 ng/mL) (P=0.006). Mbt2 in group I ranged from 30 to 597 ng/mL (n=54, median 101 ng/mL), and in group II from 141 to >700 ng/mL (n=8, median 203 ng/mL) (P=0.02).

Conclusions – In this study, Mbt0 is a moderately sensitive and specific prognostic indicator. Almost 90% of the dogs below the cutpoint survived to discharge, whereas 50% with Mbt0 above the cutpoint did not survive.

Ancillary